Progress Software Q3 GAAP diluted EPS rises 25% to $0.55; revenue slips to $246 million
Bitget2026/09/30 20:09Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Progress Software posted fiscal Q3 2026 revenue of $246 million, down 2% year over year.
- Diluted earnings per share rose 25% to $0.55, while income from operations increased 6% to $46.55 million.
- Operating margin widened 1 percentage point to 19%, and net income climbed 17% to $22.78 million.
- Annualized recurring revenue was $873 million, up from a year earlier.
- Management said the acquisition of Domo's AI and Data Platform business has closed and expects to begin integrating the business.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progress Software Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000876167-26-000110), on September 30, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
智通财经•2026/10/10 06:21
JPMorgan raises AbbVie target price to $300
格隆汇•2026/10/10 05:29
Crypto prices
MoreBitcoin
BTC
$82,756.59
+0.23%
Ethereum
ETH
$2,494.15
-0.15%
Tether USDt
USDT
$0.9991
-0.00%
BNB
BNB
$748.04
+0.68%
XRP
XRP
$1.41
+0.52%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$109.89
-0.73%
TRON
TRX
$0.3306
-0.44%
Hyperliquid
HYPE
$84.27
-1.66%
Zcash
ZEC
$1,224.72
+0.36%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now